Genpact Limited (NYSE:G) Short Interest Update

Genpact Limited (NYSE:G) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 5,510,000 shares, a decrease of 8.5% from the November 30th total of 6,020,000 shares. Approximately 3.4% of the company’s shares are short sold. Based on an average daily volume of 1,320,000 shares, the days-to-cover ratio is currently 4.2 days.

Genpact Price Performance

Genpact stock traded up $0.31 during midday trading on Wednesday, reaching $42.95. The company’s stock had a trading volume of 705,212 shares, compared to its average volume of 1,354,838. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a market cap of $7.57 billion, a PE ratio of 11.80, a price-to-earnings-growth ratio of 1.56 and a beta of 1.17. Genpact has a 52 week low of $30.23 and a 52 week high of $47.98. The business has a 50-day moving average price of $43.40 and a 200-day moving average price of $38.71.

Genpact Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 23rd. Investors of record on Monday, December 9th were issued a dividend of $0.1525 per share. This represents a $0.61 annualized dividend and a dividend yield of 1.42%. The ex-dividend date was Monday, December 9th. Genpact’s dividend payout ratio (DPR) is 16.76%.

Insider Activity at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Over the last quarter, insiders sold 23,058 shares of company stock worth $1,044,715. 2.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Genpact

Large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its holdings in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after purchasing an additional 2,060,595 shares during the period. DGS Capital Management LLC lifted its holdings in Genpact by 69.7% during the 3rd quarter. DGS Capital Management LLC now owns 45,800 shares of the business services provider’s stock worth $1,796,000 after buying an additional 18,811 shares during the period. Oddo BHF Asset Management Sas bought a new stake in shares of Genpact in the 3rd quarter valued at about $1,323,000. Franklin Resources Inc. increased its stake in shares of Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after buying an additional 252,674 shares during the period. Finally, Sanctuary Advisors LLC raised its position in shares of Genpact by 52.9% during the third quarter. Sanctuary Advisors LLC now owns 16,573 shares of the business services provider’s stock worth $650,000 after acquiring an additional 5,734 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on G shares. Jefferies Financial Group raised their price objective on Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 9th. JPMorgan Chase & Co. raised their price objective on Genpact from $35.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Needham & Company LLC increased their price target on Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, November 11th. Robert W. Baird raised their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Finally, TD Cowen upped their price target on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research note on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $42.33.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.